MM

Manmohan Madhusudan Raote

Director Director DIN 09005380
DIN 09005380 First appointment Dec 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2020
Shareholding value •••• Premium profile

About Manmohan Madhusudan Raote

Data last updated:

Manmohan Madhusudan Raote was a Director at Jash Medacs Private Limited (2020–2021) and Director at Reubens Hospitech Private Limited (2020–2021). The companies operate in Healthcare.

DIN 09005380
Primary Designation Director
Industry Healthcare
First Appointment 22 Dec 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jash Medacs Private Limited U33110MH2013PTC249435
Director22 Dec 20202013Active
Reubens Hospitech Private Limited U33309MH2018PTC309204
Director22 Dec 20202018₹9.00 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jash Medacs Private Limited
Reubens Hospitech Private Limited
Premium access

Shareholding and investment profile for Manmohan Madhusudan Raote

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manmohan Madhusudan Raote

Manmohan Madhusudan Raote was first appointed on 22 Dec 2020 as Director at Jash Medacs Private Limited.

Manmohan Madhusudan Raote held 2 earlier board appointments: Jash Medacs Private Limited (Director, 22 Dec 2020 to 24 Jul 2021); Reubens Hospitech Private Limited (Director, 22 Dec 2020 to 24 Jul 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available